- Current report filing (8-K)
November 06 2008 - 4:18PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 6, 2008
ROCHESTER MEDICAL CORPORATION
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Minnesota
|
|
0-18933
|
|
41-1613227
|
(State or other Jurisdiction of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.)
|
|
|
|
One Rochester Medical Drive, Stewartville, MN
|
|
55976
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrants telephone number, including area code:
(507) 533-9600
|
Not Applicable
|
(Former name or former address if changed since last report.)
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
1
Item 2.02. Results of Operations and Financial.
The following information is being furnished in accordance with General Instruction B.2 of Form 8-K and shall
not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange
Act), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference
in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by
specific reference in such filing.
Furnished herewith as Exhibit 99.1 and incorporated by reference herein is the text of Rochester Medical
Corporations (the Company) announcement regarding operating results for the fourth quarter and fiscal year ending
September 30, 2008, as presented in a press release dated November 6, 2008.
Item 9.01. Financial Statements and Exhibits.
The following information is being furnished in accordance with General Instruction B.2 of Form 8-K and shall
not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange
Act), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference
in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by
specific reference in such filing.
|
|
|
99.1
|
|
Press release dated November 6, 2008, of Rochester Medical Corporation
|
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned, hereunto duly authorized.
Date: November 6, 2008
ROCHESTER MEDICAL CORPORATION
By:
/s/ David A. Jonas
David A. Jonas
Chief Financial Officer
3
EXHIBIT INDEX
|
|
|
Exhibit No.
|
|
Description
|
99.1
|
|
Press release dated November 6, 2008 of Rochester Medical
Corporation
|
4
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From May 2024 to Jun 2024
Rochester Medical Corp. (MM) (NASDAQ:ROCM)
Historical Stock Chart
From Jun 2023 to Jun 2024